186 related articles for article (PubMed ID: 8006398)
21. Antimitochondrial antibody-negative primary biliary cirrhosis.
Lacerda MA; Ludwig J; Dickson ER; Jorgensen RA; Lindor KD
Am J Gastroenterol; 1995 Feb; 90(2):247-9. PubMed ID: 7847294
[TBL] [Abstract][Full Text] [Related]
22. M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena?
Davis PA; Leung P; Manns M; Kaplan M; Munoz SJ; Gorin FA; Dickson ER; Krawitt E; Coppel R; Gershwin ME
Hepatology; 1992 Nov; 16(5):1128-36. PubMed ID: 1330864
[TBL] [Abstract][Full Text] [Related]
23. Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis.
Kitami N; Komada T; Ishii H; Shimizu H; Adachi H; Yamaguchi Y; Kitamura T; Oide H; Miyazaki A; Ishikawa M
Intern Med; 1995 Jun; 34(6):496-501. PubMed ID: 7549131
[TBL] [Abstract][Full Text] [Related]
24. Antimitochondrial antibodies in kindreds of patients with primary biliary cirrhosis: antimitochondrial antibodies are unique to clinical disease and are absent in asymptomatic family members.
Caldwell SH; Leung PS; Spivey JR; Prindiville T; de Medina M; Saicheur T; Rowley M; Reddy KR; Coppel R; Jeffers LJ
Hepatology; 1992 Oct; 16(4):899-905. PubMed ID: 1398496
[TBL] [Abstract][Full Text] [Related]
25. Diversity of autoantibodies in patients with antimitochondrial antibody and their diagnostic value.
McMillan SA; Alderdice JM; McKee CM; Dawson AT; Callender ME; Fulton TT; Haire M
J Clin Pathol; 1987 Feb; 40(2):232-6. PubMed ID: 3546398
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the clinical relevance of antimitochondrial antibodies to the β- and γ-subunits of the F1F0-ATPase in patients with primary biliary cirrhosis.
Nann D; Berg CP; Preuss BE; Klein R
BMC Gastroenterol; 2012 Oct; 12():152. PubMed ID: 23095491
[TBL] [Abstract][Full Text] [Related]
27. High concentration of antimitochondrial antibodies predicts progressive primary biliary cirrhosis.
Flisiak R; Pelszynska M; Prokopowicz D; Rogalska M; Grygoruk U
World J Gastroenterol; 2005 Sep; 11(36):5706-9. PubMed ID: 16237770
[TBL] [Abstract][Full Text] [Related]
28. Response to treatment with interferon-alfa in patients with chronic hepatitis C and high titers of -M2, -M4 and -M8 antimitochondrial antibodies.
Garrido Palma G; Sánchez Cuenca JM; Olaso V; Pina R; Urquijo JJ; López Viedma B; Bustamante M; Berenguer M; Berenguer J
Rev Esp Enferm Dig; 1999 Mar; 91(3):168-81. PubMed ID: 10231308
[TBL] [Abstract][Full Text] [Related]
29. Antimitochondrial antibody profiles: are they valid prognostic indicators in primary biliary cirrhosis?
Joshi S; Cauch-Dudek K; Heathcote EJ; Lindor K; Jorgensen R; Klein R
Am J Gastroenterol; 2002 Apr; 97(4):999-1002. PubMed ID: 12003438
[TBL] [Abstract][Full Text] [Related]
30. Two different subtypes of antimitochondrial antibodies are associated with primary biliary cirrhosis: identification and characterization by radioimmunoassay and immunoblotting.
Manns M; Gerken G; Kyriatsoulis A; Trautwein C; Reske K; Meyer Zum Büschenfelde KH
Hepatology; 1987; 7(5):893-9. PubMed ID: 2443436
[TBL] [Abstract][Full Text] [Related]
31. Detection of autoantibodies against M2, LKM-1, and SLA in liver diseases by standardized uniform ELISA-techniques.
Gruber R; Felber E; Pape GR; Höchtlen-Vollmar W; Riethmüller G
J Clin Lab Anal; 1994; 8(5):284-92. PubMed ID: 7807283
[TBL] [Abstract][Full Text] [Related]
32. Antinuclear antibodies giving the 'multiple nuclear dots' or the 'rim-like/membranous' patterns: diagnostic accuracy for primary biliary cirrhosis.
Granito A; Muratori P; Muratori L; Pappas G; Cassani F; Worthington J; Guidi M; Ferri S; DE Molo C; Lenzi M; Chapman RW; Bianchi FB
Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1575-83. PubMed ID: 17206945
[TBL] [Abstract][Full Text] [Related]
33. [Immunological characteristics of primary biliary cirrhosis patients].
Yan HP; Zhuang H; Liu YM; Feng X; Tan YF; Liu Y; Zhang X; Zhao CH
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):12-6. PubMed ID: 15670483
[TBL] [Abstract][Full Text] [Related]
34. Immunoreactivity to M2 proteins in antimitochondrial antibody-negative patients with primary biliary cirrhosis.
Kitami N; Ishii H; Shimizu H; Adachi H; Komada T; Mikami H; Yokoi Y; Sato N
J Gastroenterol Hepatol; 1994; 9(1):7-12. PubMed ID: 8155871
[TBL] [Abstract][Full Text] [Related]
35. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis.
Han E; Jo SJ; Lee H; Choi AR; Lim J; Jung ES; Oh EJ
Clin Chim Acta; 2017 Jan; 464():113-117. PubMed ID: 27864100
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis.
Invernizzi P; Crosignani A; Battezzati PM; Covini G; De Valle G; Larghi A; Zuin M; Podda M
Hepatology; 1997 May; 25(5):1090-5. PubMed ID: 9141422
[TBL] [Abstract][Full Text] [Related]
37. Detection of novel non-M2-related antimitochondrial antibodies in patients with anti-M2 negative primary biliary cirrhosis.
Feuchtinger M; Christ S; Preuss B; Dengjel J; Duman S; Stevanovic S; Klein R
Gut; 2009 Jul; 58(7):983-9. PubMed ID: 19336422
[TBL] [Abstract][Full Text] [Related]
38. The predominance of IgG3 and IgM isotype antimitochondrial autoantibodies against recombinant fused mitochondrial polypeptide in patients with primary biliary cirrhosis.
Surh CD; Cooper AE; Coppel RL; Leung P; Ahmed A; Dickson R; Gershwin ME
Hepatology; 1988; 8(2):290-5. PubMed ID: 3356410
[TBL] [Abstract][Full Text] [Related]
39. Discrimination between M2 and M4 antimitochondrial antibodies in primary biliary cirrhosis.
Ghadiminejad I; Baum H
Biosci Rep; 1986 Dec; 6(12):1049-56. PubMed ID: 3555642
[TBL] [Abstract][Full Text] [Related]
40. Anti-M4 antibodies measured by a sulphite oxidase ELISA in patients with both anti-centromere and anti-M2 antibodies.
Bunn CC; McMorrow M
Clin Exp Immunol; 1995 Oct; 102(1):131-6. PubMed ID: 7554379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
